Ozempic® superior in lowering blood sugar and weight vs placebo, both in combination with SGLT-2 inhibitors

By In The News
March 4, 2019 in The Headlines

Recommended Posts

In The News

Posted March 4, 2019

- Share

Posted March 4, 2019

PLAINSBORO, N.J., March 4, 2019 /PRNewswire/ -- Novo Nordisk today announced publication of results from the SUSTAIN 9 Phase 3b trial in The Lancet Diabetes & Endocrinology. The objective of this 30 week trial was to assess the efficacy and safety of Ozempic® (semaglutide) injection 1 mg...

View the full article

Link to comment

Share on other sites

Archived

This topic is now archived and is closed to further replies.

Go to topic listing

Most Contributions
1. In The News
  222031
2. Jaydee
  17791
3. deicer
  13350
4. Kip Powick
  12311
5. dagger
  9614
Tell a friend
Love The Airline Website? Tell a friend!
- Email
- Share
Forum Statistics
- Total Topics
  
  272.4k
- Total Posts
  
  565k

Sign In

Ozempic® superior in lowering blood sugar and weight vs placebo, both in combination with SGLT-2 inhibitors

Recommended Posts

In The News

Link to comment

Share on other sites

Archived

Most Contributions

Tell a friend

Forum Statistics

Browse

Activity

Support